go-v.orgcodex
Menu
Page tools

codex · Chemistry

Zelquistinel

Diagram for Zelquistinel
Zelquistinel (GATE-251, formerly AGN-241751) is an orally active small-molecule NMDA receptor positive allosteric modulator which is under development for the treatment of major depressive disorder (MDD) by Syndeio Biosciences, and previously by Allergan. · image: Wikimedia Commons

Zelquistinel (GATE-251, formerly AGN-241751) is an orally active small-molecule NMDA receptor positive allosteric modulator which is under development for the treatment of major depressive disorder (MDD) by Syndeio Biosciences, and previously by Allergan.

Wikipedia contributors, "Zelquistinel", Wikipedia, revision 1372054537, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex